Full Press Release Details
NASHUA, N.H., Nov. 18, 2019 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that Michael Klein, Chairman and Chief Executive Officer, will present a corporate overview at the Canaccord Genuity MedTech & Diagnostics Forum, taking place Thursday, November 21st in New York City.
| Presentation Details: | |
| Date: | Thursday, November 21, 2019 |
| Time: | 10:00am Eastern Time |
| Webcast: | http://wsw.com/webcast/canaccord37/icad/ |
Headquartered in Nashua, NH, iCAD is a global medical technology leader providing innovative cancer detection and therapy solutions. For more information, visit www.icadmed.com.
Jeremy Feffer, LifeSci Advisors